Enovis Revenue and Competitors
Estimated Revenue & Valuation
- Enovis's estimated annual revenue is currently $15M per year.
- Enovis's estimated revenue per employee is $12,325
Employee Data
- Enovis has 1217 Employees.
- Enovis grew their employee count by 12% last year.
Enovis's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Technology Advisor | Reveal Email/Phone |
3 | Area VP Sales | Reveal Email/Phone |
4 | Executive Assistant to President & COO | Reveal Email/Phone |
5 | VP | Reveal Email/Phone |
6 | VP | Reveal Email/Phone |
7 | Head Operations | Reveal Email/Phone |
8 | VP Finance | Reveal Email/Phone |
9 | VP, Chief Counsel - Securities, Governance, M&A and Corporate Secretary | Reveal Email/Phone |
10 | VP Manufacturing | Reveal Email/Phone |
Enovis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 214 | 6% | N/A | N/A |
#2 | N/A | 44 | 57% | N/A | N/A |
#3 | N/A | 26 | 30% | N/A | N/A |
#4 | N/A | 28 | 40% | N/A | N/A |
#5 | N/A | 9 | 0% | N/A | N/A |
#6 | N/A | 37 | 28% | N/A | N/A |
#7 | N/A | 25 | 25% | N/A | N/A |
#8 | N/A | 5 | 67% | N/A | N/A |
#9 | N/A | 25 | 39% | N/A | N/A |
#10 | $15M | 1217 | 12% | N/A | N/A |
What Is Enovis?
Enovis™ is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, extraordinary talent and innovation, we ‘create better together’ by partnering with healthcare professionals. Our extensive range of products, services and integrated technologies fuel active lifestyles.
keywords:N/AN/A
Total Funding
1217
Number of Employees
$15M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $337.9M | 1341 | 8% | N/A |
#2 | $483.8M | 1390 | 6% | N/A |
#3 | $484M | 1411 | N/A | N/A |
#4 | $75M | 1561 | 3% | N/A |
#5 | $771.4M | 1561 | 8% | N/A |